Trends in Functional Urological Surgery in England (2013–2024): HES Database Analysis
Overview
This study analyzed Hospital Episode Statistics data from England between 2013 and 2024, revealing significant shifts in surgical management of benign lower urinary tract dysfunction. Notably, there was a drastic decline in mid-urethral tape insertions for stress urinary incontinence, with bulking agents becoming the predominant treatment. Additionally, evolving techniques for benign prostatic enlargement and changes in surgical volumes for post-prostatectomy incontinence and vesicovaginal fistula repair were observed.
Background
Benign lower urinary tract dysfunction, including benign prostatic enlargement (BPE) and urinary incontinence (UI), represents a substantial health burden globally. Surgical management options have evolved over the past decade, influenced by new technologies, clinical guidelines, and regulatory changes such as the mesh pause. In men, BPE treatments range from TURP to laser enucleation and minimally invasive therapies, while female UI management includes mid-urethral slings, bulking agents, and colposuspension. Post-prostatectomy incontinence and vesicovaginal fistulas require tailored surgical approaches depending on severity and complexity.
Data Highlights
Procedure
2013–2018 Avg. Annual Procedures
2019–2024 Avg. Annual Procedures
Trend
Mid-urethral Tape Insertion (TVT/TOT)
8319 (SD 2775)
8 (SD 5)
Significant Downtrend
Tape Removal
425 (SD 176)
425 (SD 176)
Significant Downtrend
Bulking Agents
Below Tape Insertion
2490 (SD 819)
Significant Uptrend
Colposuspension
467 (SD 221)
467 (SD 221)
Small but Significant Increase
Fascial Sling Insertion
Brief Increase 2018–2020
21 (SD 1.6) from 2021 onwards
No Sustained Significant Change
Key Findings
Mid-urethral tape insertions for female stress urinary incontinence decreased dramatically from an average of 8319/year (2013–2018) to 8/year (2019–2024).
Tape removal procedures averaged 425 annually but also showed a significant downtrend over the decade.
Use of urethral bulking agents increased significantly, surpassing tape insertions in 2019 and becoming the main treatment for stress urinary incontinence.
Colposuspension procedures showed a small but statistically significant increase during the study period.
Fascial sling insertions had a transient rise between 2018 and 2020 but stabilized at low numbers thereafter without significant sustained change.
Mean patient ages for tape insertion and removal were in the early to mid-50s, similar to those for female sling insertion and bulking agents.
Clinical Implications
The near cessation of mid-urethral tape insertions reflects changing clinical practice likely influenced by regulatory scrutiny and patient safety concerns. Bulking agents have emerged as the preferred surgical option for female stress urinary incontinence, offering a less invasive alternative. Clinicians should consider these evolving trends when counseling patients and selecting surgical interventions, balancing efficacy, safety, and patient preferences.
Conclusion
Over the past decade in England, functional urological surgery has undergone significant shifts, particularly in female stress urinary incontinence management, with a marked decline in mid-urethral tape use and increased reliance on bulking agents. These trends underscore the dynamic nature of surgical practice influenced by technological advances and regulatory changes.
References
NICE Guidelines 2019 -- Management of Lower Urinary Tract Symptoms
NHS Digital HES Database 2013-2024 -- Surgical Procedure Data
Cumberledge Report 2018 -- Mesh Pause and Impact on UI Surgery